Quality is paramount at Optimus, we’re committed to providing high-quality products through our Operational excellence, stringent Quality policies, QBD approach towards product development.
Founded with the goal of providing high-quality, low-cost products to those in need. Our R&D capabilities and backwards integration methodology assist us in developing affordable products.
In both SCM & manufacturing processes, our seamless approaches provide efficiency and productivity. This enables us to provide low-cost, high-quality products, resulting in high customer satisfaction.
We value our customers, employees, community, & consumers. We are committed to providing the best value to all the stakeholders and bringing new treatment options for people in need.
Optimus is one of the fastest-growing pharmaceutical companies with 16 years of experience in providing the best quality of API, Intermediates & Finished formulations in Global markets. Our aim from day one has been to provide and ensure better healthcare across the globe through our research, Innovations, affordable products & manufacturing excellence.Read more
Years of Experience
Well-equipped standalone Research and Development lab with 150+ professional scientists with strong knowledge in API & Finished formulations.
Our backward integration with intermediate & API manufacturing enables us to be highly competitive, sustaining, & maintaining a high quality of the products.
Optimus focuses on developing complex and niche molecules; We develop and commercialize products based on future potential and in line with market demand.
The core competence of Optimus lies in its ability to deliver from the gram scale to multi-ton levels.
Optimus is committed to maintaining the best quality standards in the research & development and manufacturing of pharmaceutical products through complying with our stringent quality policies.
Optimus Pharma receives restricted emergency use Authorization for Molnupiravir in india.Read more
Optimus Drugs and Optimus Pharma Pvt Ltd. qualified for the Production Linked Incentive (PLI) scheme for the Pharmaceutical Sector.Read more